P oint-of-care HbA 1c measurements (POC-A1Cs) have been adopted by many diabetes clinics to improve the quality of care provided to their patients (1) . Herein, we show that reliability of this approach might be questioned. POC-A1Cs routinely used in the ambulatory section of our diabetes clinic was evaluated on 100 diabetic patients (type 1, n 5 58; type 2, n 5 42) attending the clinic from 1 HbA 1c values obtained from POC-A1C were found to be below those given by the central laboratory in 98% of the cases. POC-A1C values differed by a mean of 20.50 6 0.28%. Central laboratory and the POC-A1C values were correlated, but the regression equation suggested a slight proportional bias (slope: 0.87) and a greater constant bias (intercept with y-axis: 0.37%). BlandAltman statistics showed a significant correlation between the delta and the mean of HbA 1c . The higher the HbA 1c value was, the greater the discrepancy between both methods. To evaluate whether these discrepancies in HbA 1c values can interfere with decision making, we assessed the possible POC-A1C-induced errors in categorization at the different HbA 1c threshold levels used by the clinicians to modify hypoglycemic treatment. If the therapeutic HbA 1c objective was #6.5%, then 11% of the population was incorrectly considered in the target by POC-A1C. This proportion of misclassification increased to 24% when the therapeutic target was #7% and decreased thereafter (#7.5%, 12%; #8.0%, 8%). The higher misclassification rate observed for a 7% threshold is due to the fact that the proportion of patients around this value is especially high in our unselected cohort (HbA 1c median: 7.28%). This real-life analysis differed from bench tests, which are usually performed to validate POC-A1C methods (2) . Similar tendencies to an underevaluation of HbA 1c by POC methods have been noted already by Holmes et al. 
